Short-term exposure to intermittent hypoxia leads to changes in gene expression seen in chronic pulmonary disease.
Gang WuYin Yeng LeeEvelyn M GullaAndrew PotterJoseph KitzmillerMarc D RubenNathan SalomonisJeffery A WhitsettLauren J FranceyJohn B HogeneschDavid F SmithPublished in: eLife (2021)
Obstructive sleep apnea (OSA) results from episodes of airway collapse and intermittent hypoxia (IH) and is associated with a host of health complications. Although the lung is the first organ to sense changes in oxygen levels, little is known about the consequences of IH to the lung hypoxia-inducible factor-responsive pathways. We hypothesized that exposure to IH would lead to cell-specific up- and downregulation of diverse expression pathways. We identified changes in circadian and immune pathways in lungs from mice exposed to IH. Among all cell types, endothelial cells showed the most prominent transcriptional changes. Upregulated genes in myofibroblast cells were enriched for genes associated with pulmonary hypertension and included targets of several drugs currently used to treat chronic pulmonary diseases. A better understanding of the pathophysiologic mechanisms underlying diseases associated with OSA could improve our therapeutic approaches, directing therapies to the most relevant cells and molecular pathways.
Keyphrases
- pulmonary hypertension
- obstructive sleep apnea
- endothelial cells
- gene expression
- induced apoptosis
- positive airway pressure
- cell cycle arrest
- single cell
- cell therapy
- poor prognosis
- healthcare
- public health
- pulmonary arterial hypertension
- type diabetes
- cell death
- risk factors
- adipose tissue
- oxidative stress
- coronary artery
- long non coding rna
- cancer therapy
- risk assessment
- metabolic syndrome
- binding protein
- health information
- heat stress
- pulmonary fibrosis